Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker

Documenti analoghi

• What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
  di: Yao, Yu, et al.
  Pubblicazione: (2021)
• Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti.
  di: Suzuki, S, et al.
  Pubblicazione: (2001)
• H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma
  di: Dan Yang, et al.
  Pubblicazione: (2019-02-01)
• H(2)S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma
  di: Yang, Dan, et al.
  Pubblicazione: (2019)
• Diaryl Hydroxylamines as Pan or Dual Inhibitors of Indoleamine 2,3-Dioxygenase-1, Indoleamine 2,3-Dioxygenase-2 and Tryptophan Dioxygenase
  di: Winters, Maria, et al.
  Pubblicazione: (2018)